These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19482254)

  • 1. Liver transplantation and management of the hepatitis B virus. Preface.
    Rizzetto M
    Dig Liver Dis; 2009 May; 41 Suppl 2():S183. PubMed ID: 19482254
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of de novo hepatitis B virus infections: more seems no better.
    Mutimer D
    Liver Transpl; 2010 Mar; 16(3):256-8. PubMed ID: 20209586
    [No Abstract]   [Full Text] [Related]  

  • 3. Developing strategies for prevention and treatment of recurrent HBV in liver transplantation.
    Nery JR; Weppler D; Lavandera R; Nery Avila C; Magill A; Rodriguez M; Reddy KR; Schiff E; Tzakis AG
    Transplant Proc; 1999; 31(1-2):485-6. PubMed ID: 10083202
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver transplantation for hepatitis B virus. Pre-emptive and peri-operative prophylaxis.
    Mas A
    Dig Liver Dis; 2009 May; 41 Suppl 2():S191-4. PubMed ID: 19482256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Managing lamivudine resistance in liver transplantation for hepatitis B liver disease].
    Samuel D
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S26-30. PubMed ID: 17075493
    [No Abstract]   [Full Text] [Related]  

  • 6. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.
    Gane EJ; Angus PW; Strasser S; Crawford DH; Ring J; Jeffrey GP; McCaughan GW;
    Gastroenterology; 2007 Mar; 132(3):931-7. PubMed ID: 17383422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation.
    Rosenau J; Tillmann HL; Bahr MJ; Trautwein C; Boeker KH; Nashan B; Klempnauer J; Manns MP
    Transplant Proc; 2001; 33(7-8):3637-8. PubMed ID: 11750544
    [No Abstract]   [Full Text] [Related]  

  • 8. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
    Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.
    Angus PW; McCaughan GW; Gane EJ; Crawford DH; Harley H
    Liver Transpl; 2000 Jul; 6(4):429-33. PubMed ID: 10915163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between levels of anti-HBS with a fixed administration dose of HBIG and a combination of HBIG and lamivudine for the prophylaxis of hepatitis B after liver transplantation.
    Sousa JM; Pareja F; Serrano J; Gómez MA; García I; Tamayo MJ; Díaz C; Martín C; Pascasio JM; Hinojosa R; Pérez-Bernal JB; Cañas E; Sayago M; Bernardos A
    Transplant Proc; 2003 Mar; 35(2):723-4. PubMed ID: 12644112
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of recurrent hepatitis B post-liver transplantation.
    Lok AS
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S67-73. PubMed ID: 12362302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation and hepatitis B virus infection: the situation seems to be under control, but the virus is still there.
    Samuel D
    J Hepatol; 2001 Jun; 34(6):943-5. PubMed ID: 11451182
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing virologic efficacy of combination lamivudine and low-dose hepatitis B immune globulin posttransplantation with the ultrasensitive digene hybrid capture II assay.
    Yoshida EM; Sherlock CH
    Liver Transpl; 2000 May; 6(3):386. PubMed ID: 10858081
    [No Abstract]   [Full Text] [Related]  

  • 14. The option of liver transplantation for hepatitis B: where are we?
    Samuel D
    Dig Liver Dis; 2009 May; 41 Suppl 2():S185-9. PubMed ID: 19482255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation.
    Zheng SS; Wu J; Liang TB; Wang WL; Huang DS; Xu X
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):327-9. PubMed ID: 14607701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy in prevention of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine.
    Lee KW; Lee SK; Joh JW; Kim SJ; Park JH; Chon SE; Choi SH; Heo JS; Paik SW; Koh KW; Lee JH; Choi MS; Kim YI; Lee BB
    Transplant Proc; 2001; 33(7-8):3643-4. PubMed ID: 11750547
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis B immunoglobulin treatment after liver transplantation--our experiences].
    Roznovský L; Kloudová A; Kabieszová L; Dedek V; Orságová I; Zjevíková A
    Klin Mikrobiol Infekc Lek; 2007 Apr; 13(2):76-9. PubMed ID: 17599297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapy for pre- and post-liver transplantation patients with hepatitis B.
    Tan J; Lok AS
    Liver Transpl; 2007 Mar; 13(3):323-6. PubMed ID: 17318864
    [No Abstract]   [Full Text] [Related]  

  • 19. Decision analysis model for hepatitis B prophylaxis one year after liver transplantation.
    Saab S; Ham MY; Stone MA; Holt C; Tong M
    Liver Transpl; 2009 Apr; 15(4):413-20. PubMed ID: 19326401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis of hepatitis B virus recurrence after liver transplantation.
    Testino G; Borro P; Sumberaz A
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):139-41. PubMed ID: 19565040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.